Phenotypic characterization of telomerase-immortalized primary non-malignant and malignant tumor-derived human prostate epithelial cell lines.
about
LEF1 in androgen-independent prostate cancer: regulation of androgen receptor expression, prostate cancer growth, and invasionEstablishment and characterization of Caspian horse fibroblast cell bank in Iran.Epithelial to mesenchymal transition of a primary prostate cell line with switches of cell adhesion modules but without malignant transformation.Transcription factor Stat3 stimulates metastatic behavior of human prostate cancer cells in vivo, whereas Stat5b has a preferential role in the promotion of prostate cancer cell viability and tumor growth.Evaluation of ERG responsive proteome in prostate cancerEstablishment and characterization of a highly tumorigenic African American prostate cancer cell line, E006AA-hT.Culture, immortalization, and characterization of human meibomian gland epithelial cells.Macromolecular therapeuticsPharmacologic inhibition of Jak2-Stat5 signaling By Jak2 inhibitor AZD1480 potently suppresses growth of both primary and castrate-resistant prostate cancer.Deletion of the olfactomedin 4 gene is associated with progression of human prostate cancer.MiRNA 26a expression in a novel panel of African American prostate cancer cell linesSelective inhibitory effect of HPMA copolymer-cyclopamine conjugate on prostate cancer stem cells.Transplantation of Immortalized CD34+ and CD34- Adipose-Derived Stem Cells Improve Cardiac Function and Mitigate Systemic Pro-Inflammatory ResponsesContext dependent regulatory patterns of the androgen receptor and androgen receptor target genesStimulation of prostate cancer cellular proliferation and invasion by the androgen receptor co-activator ARA70Chromosomal aberrations in benign prostatic hyperplasia patientsProstate cell cultures as in vitro models for the study of normal stem cells and cancer stem cells.The cellular and molecular carcinogenic effects of radon exposure: a review.Prostate cancer and metastasis initiating stem cells.Inhibition of metastatic potential in colorectal carcinoma in vivo and in vitro using immunomodulatory drugs (IMiDs).HPMA copolymer-based combination therapy toxic to both prostate cancer stem/progenitor cells and differentiated cells induces durable anti-tumor effects.Label-free screening assays: a strategy for finding better drug candidates.Characterization of the androgen receptor in a benign prostate tissue-derived human prostate epithelial cell line: RC-165N/human telomerase reverse transcriptase.Metastatic state of parent cells influences the uptake and functionality of prostate cancer cell-derived extracellular vesicles.Regulation of HMGA1 expression by microRNA-296 affects prostate cancer growth and invasionStudy on characteristics of in vitro culture and intracellular transduction of exogenous proteins in fibroblast cell line of Liaoning cashmere goat.Mifepristone inhibits GRβ coupled prostate cancer cell proliferation.TGFβ1-Endo180-dependent collagen deposition is dysregulated at the tumour-stromal interface in bone metastasis.Establishment and characterization of a fibroblast cell line derived from Mongolian sheep.Modulation of TGF-β-inducible hypermotility by EGF and other factors in human prostate epithelial cells and keratinocytes.Establishment and characterization of a fibroblast cell line derived from Texel sheep.Increased expression of histone deacetylaces (HDACs) and inhibition of prostate cancer growth and invasion by HDAC inhibitor SAHA.Hypoacetylation, hypomethylation, and dephosphorylation of H2B histones and excessive histone deacetylase activity in DU-145 prostate cancer cells.
P2860
Q24313620-6C4ABB91-0550-4F36-8F12-732C36B111CCQ32183403-EA18AFE8-A56D-46B7-BE48-7048DE8DE67AQ33375703-9EF08943-3558-4FC4-9BA4-3874F24C80D2Q33745272-8E02D37F-9185-4408-BB63-8AEE0F6E96CEQ33822319-66B0BD28-1E33-40B0-B378-0643CD8A7084Q33970160-84741978-7117-4C7E-A7F7-000629EE6F31Q34022565-42EC52F4-5BAA-4A98-AD8E-07A79A45C33EQ34079574-BCD3E07C-6AA6-4390-BF8F-30C148FD7B4BQ34363785-15A387FE-F1ED-41E1-B29A-B0F9055072AAQ35000190-B28DE302-152E-4035-AFFC-45A54C85180FQ35053774-CC36F19E-76B2-43A7-B02A-022DA47CE4E3Q35624160-E7385D8B-F8FA-48BC-8443-3389721A34D5Q35913001-D1A32B81-7508-40B1-B7D9-EFBD05EC1A51Q36067956-9E17692E-01C9-4541-8D4A-24308599569BQ36357367-B27960A6-A0AA-4384-9279-DB1D3E74B819Q36653005-3E7A8837-3F3F-413F-ABAC-74B3A6731B15Q36994174-DFC0D53F-600B-4CE2-BAA8-3A2367A73414Q37091897-3E48F1DA-CAD1-42E5-AD17-CB001DC276F6Q37139272-1D11B711-D75F-41C4-8303-F93431C6F299Q37330741-6FF4441E-B8BC-4807-8DA7-0B822E56063CQ37381330-9F62C496-BC99-4C90-9D7D-82D7DDE60728Q37856304-23CF92AA-26CA-4FC6-9158-8D093FF9C54AQ38308020-3EA2385B-47F9-44D6-BCDB-F8EB14D92DF4Q38694648-0DAF804B-7F21-442F-AED3-91AFF8448C19Q38751649-B38C327F-3A06-4948-A5F9-E10E4CC5D76AQ39259407-282B8CCD-00A1-4AC9-9FB0-66B31A920B00Q39310940-E08D8553-00DA-4740-9501-DC1C9FC2A46FQ39445552-A2C26027-4BAE-4119-9AFE-9C137E8E50B9Q39512631-D0921104-00A0-4F00-A092-831CA371FA15Q39636923-37025870-F7C5-455B-A4AC-1E1EEA34FA30Q39850157-6F9BB361-5FC2-4455-AE5E-1242F202EEABQ41881419-358A8C78-1495-465D-B129-46AE1982C873Q43092820-405DF0D8-F990-4562-AAF6-512F2B978516
P2860
Phenotypic characterization of telomerase-immortalized primary non-malignant and malignant tumor-derived human prostate epithelial cell lines.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Phenotypic characterization of ...... rostate epithelial cell lines.
@en
Phenotypic characterization of ...... rostate epithelial cell lines.
@nl
type
label
Phenotypic characterization of ...... rostate epithelial cell lines.
@en
Phenotypic characterization of ...... rostate epithelial cell lines.
@nl
prefLabel
Phenotypic characterization of ...... rostate epithelial cell lines.
@en
Phenotypic characterization of ...... rostate epithelial cell lines.
@nl
P2093
P4510
P1476
Phenotypic characterization of ...... rostate epithelial cell lines.
@en
P2093
Charles M Ewing
David G McLeod
Hongzhen Li
Isabell A Sesterhenn
Johng S Rhim
Kee-Hong Kim
Shiv Srivastava
Wei-Sing Chu
William B Isaacs
P304
P356
10.1016/J.YEXCR.2005.11.029
P407
P577
2006-01-17T00:00:00Z